Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Weinstock-Guttman

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Human Immunology|April 17, 1998
HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosisM Yu, R P Kinkel, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosisR H B Benedict, I Fishman, M M McClellan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities TestB A Parmenter, B Weinstock-Guttman, N Garg, et al.
Neurology|April 18, 2007
MRI features of pediatric multiple sclerosisB Banwell, M Shroff, J M Ness, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2006
Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosisS D Brass, R H B Benedict, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 27, 2009
Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MSL Strober, J Englert, F Munschauer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up studyR A Bermel, B Weinstock-Guttman, D Bourdette, et al.
The New England Journal of Medicine|November 27, 1997
Management of multiple sclerosisR A Rudick, J A Cohen, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2011
Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1aD M Miller, B Weinstock-Guttman, D Bourdette, et al.
Neurology|April 18, 2007
Clinical features of children and adolescents with multiple sclerosisJ M Ness, D Chabas, A D Sadovnick, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Human Immunology|April 17, 1998
HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosisM Yu, R P Kinkel, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosisR H B Benedict, I Fishman, M M McClellan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities TestB A Parmenter, B Weinstock-Guttman, N Garg, et al.
Neurology|April 18, 2007
MRI features of pediatric multiple sclerosisB Banwell, M Shroff, J M Ness, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2006
Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosisS D Brass, R H B Benedict, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 27, 2009
Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MSL Strober, J Englert, F Munschauer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up studyR A Bermel, B Weinstock-Guttman, D Bourdette, et al.
The New England Journal of Medicine|November 27, 1997
Management of multiple sclerosisR A Rudick, J A Cohen, B Weinstock-Guttman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 9, 2011
Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1aD M Miller, B Weinstock-Guttman, D Bourdette, et al.
Neurology|April 18, 2007
Clinical features of children and adolescents with multiple sclerosisJ M Ness, D Chabas, A D Sadovnick, et al.
Pageof 11